Literature DB >> 18475610

Platelet-activating factor mediates trinitrobenzene induced dysmotility in the left colon.

W E Longo1, J Standeven, B Chandel, Y Deshpande, A M Vernava, D Kaminski.   

Abstract

We investigated whether TNB alters colonic tissue levels of PAF at the expense of changes in colonic motility in the isolated perfused rabbit left colon. Colonic inflammation was induced by the intracolonic administration of 0.25 ml of 50% ethanol containing 30 mg of trinitrobenzene. Strain gauge transducers were sewn onto the serosal surface of the colon to evaluate colonic motility. TNB administration increased tissue levels of PAF and increased the average force of each colonic contraction. Pretreatment with the PAF receptor antagonist WEB-2170 prior to TNB infusion decreased tissue concentrations of PAF and ameliorated the altered motility parameters seen with TNB alone. These results suggest that PAF is stimulated by TNB and may participate in colonic dysmotility during inflammatory states.

Entities:  

Year:  1995        PMID: 18475610      PMCID: PMC2365612          DOI: 10.1155/S0962935195000032

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  5 in total

1.  Leukotriene D4 participates in colonic transit disturbances induced by intracolonic administration of trinitrobenzene sulfonic acid in rats.

Authors:  L Pons; M T Droy-Lefaix; L Bueno
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

2.  Involvement of platelet-activating factor (PAF) in endotoxin-induced intestinal motor disturbances in rats.

Authors:  L Pons; M T Droy-Lefaix; P Braquet; L Buéno
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

3.  The role of prostanoids in the production of acute acalculous cholecystitis by platelet-activating factor.

Authors:  D L Kaminski; C H Andrus; D German; Y G Deshpande
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

4.  Platelet-activating factor and interleukin 1 are involved in colonic dysmotility in experimental colitis in rats.

Authors:  O Morteau; J More; L Pons; L Bueno
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

5.  In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Gastroenterology       Date:  1988-07       Impact factor: 22.682

  5 in total
  1 in total

1.  Clostridium difficile suppresses colonic vasoactive intestinal peptide associated with altered motility.

Authors:  A Nassif; W E Longo; R Sexe; M Stratton; J Standeven; A M Vernava; D L Kaminski
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.